Literature DB >> 6529453

Severe bronchopulmonary dysplasia in the very low birth weight infant: its relationship to developmental outcome.

E Goldson.   

Abstract

The purpose of this study was to evaluate the developmental outcome of a group of very low birth weight children (VLBW) with and without severe bronchopulmonary dysplasia (BPD), at the time of discharge from the nursery. Children matched for birth weight and gestational age with mild or no BPD served as controls. All of the children were evaluated developmentally at two years of age, using the Bayley Scales of Infant Development. Neuromotor function was assessed by occupational and physical therapists. The data suggested that children with severe BPD performed more poorly on developmental testing and had a higher incidence of neuromotor pathology than did controls. However, the controls did manifest suspicious neuromotor findings. The data suggest that infants with BPD are not a homogeneous group. Very low birth weight infants, whether or not they have severe BPD, are at risk for having developmental delays. These infants should be closely monitored from the time of nursery discharge.

Entities:  

Mesh:

Year:  1984        PMID: 6529453

Source DB:  PubMed          Journal:  J Dev Behav Pediatr        ISSN: 0196-206X            Impact factor:   2.225


  3 in total

1.  A research database for improved data management and analysis in longitudinal studies.

Authors:  R A Bielefeld; T S Yamashita; E F Kerekes; E Ercanli; L T Singer
Journal:  MD Comput       Date:  1995 May-Jun

2.  Early motor and mental development in very preterm infants with chronic lung disease.

Authors:  M Katz-Salamon; E M Gerner; B Jonsson; H Lagercrantz
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-07       Impact factor: 5.747

3.  Neurodevelopmental outcome of preterm infants with bronchopulmonary dysplasia.

Authors:  P H Gray; Y R Burns; H A Mohay; M J O'Callaghan; D I Tudehope
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1995-11       Impact factor: 5.747

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.